• KBR recently announced it was selected to license its PureSAF technology and deliver Front-End Engineering Design for a proposed Sustainable Aviation Fuel plant on Singapore’s Jurong Island, which is being developed by Keppel’s Infrastructure Division and Aster Chemicals and Energy with a planned capacity of up to 100,000 tons of SAF per year, subject to approvals.
• Beyond this single project, KBR’s related Memorandum of Intent with Keppel to collaborate on wider decarbonization and energy transition technologies points to a broader role for its proprietary process know-how in emerging low-carbon fuel and waste-to-energy markets.
• We’ll now examine how this PureSAF licensing and FEED win, alongside broader decarbonization cooperation with Keppel, reshapes KBR’s investment narrative.

Find 43 companies with promising cash flow potential yet trading below their fair value.

KBR Investment Narrative Recap

To own KBR, you essentially have to believe that its pivot toward higher value sustainable technologies and government solutions can offset recent share price weakness and modest growth expectations. The PureSAF win with Keppel supports the energy transition side of that story, but it does not change the fact that the most immediate catalyst remains improved contract awards and backlog conversion, while key risks still center on government funding delays and execution around the planned Mission Technology Solutions spin off.

Among the recent announcements, the appointment of leadership for the Mission Technology Solutions spin off feels particularly relevant. As KBR ramps up SAF and broader decarbonization work with Keppel, clarity on how a future pure play government and defense services entity will be run matters for how investors think about capital allocation, earnings quality and the balance between technology licensing, defense exposure and higher debt on the remaining KBR business.

Yet against these opportunities, investors should be aware that the same spin off that could unlock value also introduces concentrated execution and funding risk across...

KBR's narrative projects $8.9 billion revenue and $501.9 million earnings by 2029.

Uncover how KBR's forecasts yield a $46.57 fair value, a 28% upside to its current price.

Exploring Other Perspectives

Some of the lowest ranked analysts were already assuming only about 2.7 percent annual revenue growth to roughly US$8.3 billion and flat earnings around US$429 million, so this new SAF contract and related catalyst could challenge that more cautious view and may prompt you to compare how your expectations differ from theirs.

Explore 6 other fair value estimates on KBR - why the stock might be worth 7% less than the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your KBR research is our analysis highlighting 5 key rewards and 1 important warning sign that could impact your investment decision.
• Our free KBR research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate KBR's overall financial health at a glance.

Contemplating Other Strategies?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• Outshine the giants: these 16 early-stage AI stocks could fund your retirement.
• AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Uncover the next big thing with 20 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.